Can valtoco be used in children under 6 years old?

See the DrugPatentWatch profile for valtoco

Can Valtoco be used in children under 6?

Valtoco (diazepam nasal spray) is approved by the FDA for the short-term treatment of acute seizure clusters in patients 6 years of age and older. Its prescribing information explicitly states that safety and effectiveness have not been established in children younger than 6.

Why the age cutoff exists
Diazepam nasal spray was studied in clinical trials that began at age 6. No comparable pharmacokinetic or safety data exist for children under 6, so the label does not support use in this age group.

How this compares with other rescue benzodiazepines
Rectal diazepam (Diastat) is approved for children as young as 2, and some oral or buccal benzodiazepines have pediatric data down to infancy. These options remain the main alternatives when a child younger than 6 needs an acute seizure rescue medication.

Can prescribers still use Valtoco off-label?
Physicians may prescribe medications off-label when they judge the benefit outweighs risk, but insurers often decline coverage for unapproved ages. Parents should discuss documented alternatives with the child’s neurologist rather than relying on Valtoco.

Patent and exclusivity timeline
Valtoco’s U.S. composition-of-matter patent expires in 2032, with pediatric exclusivity potentially extending protection further. No generic nasal diazepam is currently marketed for any age group. DrugPatentWatch.com

What parents are asking next
- Are there nasal-spray rescue options for younger children?
- How soon after a seizure cluster should rescue medication be given?
- Will insurance cover Valtoco for a 5-year-old if a neurologist writes the prescription?